Research Article
Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: Experimental and computational studies
Article first published online: 22 AUG 2002
DOI: 10.1002/jps.10237
Copyright © 2002 Wiley-Liss, Inc.
Total views since August 2010: 47
Additional Information
How to Cite
Perdomo-López, I., Rodríguez-Pérez, A.I., Yzquierdo-Peiró, J.M., White, A., Estrada, E.G., Villa, T.G. and Torres-Labandeira, J.J. (2002), Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: Experimental and computational studies. J. Pharm. Sci., 91: 2408–2415. doi: 10.1002/jps.10237
Publication History
- Issue published online: 22 AUG 2002
- Article first published online: 22 AUG 2002
- Manuscript Accepted: 4 JUN 2002
- Manuscript Revised: 30 MAY 2002
- Manuscript Received: 30 JAN 2002
Keywords:
- sertaconazole nitrate;
- cyclodextrins;
- solubility;
- antimycotic effect;
- molecular modeling
Abstract
This study investigated the effects of the complexation of sertaconazole nitrate with different cyclodextrin (CD) derivatives (α-CD, β-CD, γ-CD, hydroxypropyl-β-CD, and hydroxypropyl-γ-CD) on the aqueous solubility and antimycotic activity of the drug. Phase solubility studies indicated that the solubility of sertaconazole in enzyme-free simulated gastric- and enzyme-free simulated enteric fluids was significantly increased in the presence of cyclodextrins. The observed order of solubility increasing effect was: γ-CD > HPγ-CD > HPβ-CD > β-CD > α-CD. Solid-state sertaconazole–cyclodextrin complexes were prepared by freeze drying, and characterized by X-ray powder difractometry, differential scanning calorimetry (DSC), and infrared spectroscopy (FTIR). Freeze-dried complexes showed markedly higher solubility than both physical mixtures and sertaconazole alone. The antimycotic activities of sertaconazole–cyclodextrin complexes in solution were evaluated by inhibition zone assays with Candida albicans. The activity ranking agrees with the solubility ranking observed for these complexes, with the γ-CD–sertaconazole complex showing the strongest antimycotic activity. Finally, molecular modeling studies were carried out using the MM2 force field method, for complexes in vacuum and in water. This enable indentification of the preferred orientation of sertaconazole in the γ-CD cavity and of the main structural features responsible for the enhancement of its solubility and antimycotic activity. © 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2408–2415, 2002

1520-6017/asset/JPS_left.gif?v=1&s=becd26fac43b87042ad04af68bbe20d6a12e64fc)
1520-6017/asset/olbannerright.jpg?v=1&s=254f44b422de0f476861bd1056a1789033e2171c)
1520-6017/asset/cover.gif?v=1&s=e589ccf35fd012c675e943835781318cb8666bed)